RT Journal Article
SR Electronic
T1 Temporal Dynamics of Viral Load and False negative Rate Influence the Levels of Testing Necessary to Combat COVID19 Spread
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.12.20173831
DO 10.1101/2020.08.12.20173831
A1 Jarvis, Katherine F.
A1 Kelley, Joshua B.
YR 2020
UL http://medrxiv.org/content/early/2020/08/18/2020.08.12.20173831.abstract
AB Many colleges and other organizations are considering testing plans to return to operation as the COVID19 pandemic continues. The temporal dynamics of viral load and test false negative rate have the potential to alter the apparent efficacy of testing, as testing must identify a sick individual prior to that person transmitting the virus to one or more people and isolate them. High levels of pre-symptomatic spread and high false negative rates for testing make it difficult to successfully test an individual in the time frame necessary to stop viral spread. Here, we develop a stochastic agent-based model of COVID19 in a university sized population, considering the dynamics of both viral load and false negative rate of tests on the ability of testing to combat viral spread. We find that the undetectable period of SARS-CoV-2 can lead to an apparent false negative rate of ~17% in the presence of a hypothetical perfect test, while full implementation of dynamic false negative rates reported in the literature leads to an overall false negative rate of ~48%. We then compare testing while varying fraction of the population and the frequency of testing. We find that these assumptions about viral load and false negative rate lead to a requirement for high levels of both frequency and fraction of population tested in order to bring the apparent Reproduction number (Rt) below 1. We conclude that it is important to consider the non-uniform dynamics of viral spread and false negative rate in order to produce realistic testing plans that will lead to the desired reduction in Rt to control viral spread.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWork supported by NIH R15 GM128026 to JBKAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB approval not needed.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesdata and matlab scripts necessary to reproduce this work are available at GitHub https://github.com/Kelley-Lab-Computational-Biology/coronamodel